We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Markel (MKL) Q2 Earnings & Revenues Top Estimates, Up Y/Y
Read MoreHide Full Article
Markel Corporation (MKL - Free Report) delivered second-quarter 2018 income of $19.97 per share, surpassing the Zacks Consensus Estimate of $8.49. Moreover, the bottom line more than doubled year over year.
Markel Corporation Price, Consensus and EPS Surprise
The company witnessed higher revenues and improved premiums at the Insurance segment. However, increase in expenses was a dampener.
Operational Update
Total operating revenues of $1.8 billion exceeded the Zacks Consensus Estimate by 11.7%. Also, the top line improved 28.6% year over year on higher premiums, investment income and other revenues.
Total operating expenses of Markel escalated about 35% year over year to $1.7 billion.
Markel’s combined ratio deteriorated 300 basis points (bps) year over year to 92% in the reported quarter.
Segment Update
Insurance: Net written premiums were up 9.1% year over year to $1 billion in the quarter under review.
Underwriting profit was nearly $74.3 million, down 0.2% year over year.
Combined ratio improved 100 bps year over year to 92% in the quarter under discussion.
Reinsurance: Net written premiums declined about 18.9% year over year to $208.8 million.
Underwriting profit was nearly $23.6 million, down 31% year over year.
Combined ratio deteriorated 500 bps year over year to 90% in the second quarter.
Financial Update
Markel exited the second quarter with investments, cash and cash equivalents plus restricted cash and cash equivalents of $20.4 billion, down 0.8% from the level at year-end 2017.
Debt balance decreased 2.4% to $3 billion as of Jun 30, 2018 from $3.1 billion at 2017 end.
Book value per share slipped 1.8% from the tally at year-end 2017 to $682.76 as of Jun 30, 2018.
Net cash from operating activities for the first half was $307.5 million, up 29.2% year over year.
Among other players from the insurance industry having already reported second-quarter earnings, the bottom line of The Progressive Corporation (PGR - Free Report) , MGIC Investment Corporation (MTG - Free Report) and RLI Corp. (RLI - Free Report) outpaced the respective Zacks Consensus Estimate.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Markel (MKL) Q2 Earnings & Revenues Top Estimates, Up Y/Y
Markel Corporation (MKL - Free Report) delivered second-quarter 2018 income of $19.97 per share, surpassing the Zacks Consensus Estimate of $8.49. Moreover, the bottom line more than doubled year over year.
Markel Corporation Price, Consensus and EPS Surprise
Markel Corporation Price, Consensus and EPS Surprise | Markel Corporation Quote
The company witnessed higher revenues and improved premiums at the Insurance segment. However, increase in expenses was a dampener.
Operational Update
Total operating revenues of $1.8 billion exceeded the Zacks Consensus Estimate by 11.7%. Also, the top line improved 28.6% year over year on higher premiums, investment income and other revenues.
Total operating expenses of Markel escalated about 35% year over year to $1.7 billion.
Markel’s combined ratio deteriorated 300 basis points (bps) year over year to 92% in the reported quarter.
Segment Update
Insurance: Net written premiums were up 9.1% year over year to $1 billion in the quarter under review.
Underwriting profit was nearly $74.3 million, down 0.2% year over year.
Combined ratio improved 100 bps year over year to 92% in the quarter under discussion.
Reinsurance: Net written premiums declined about 18.9% year over year to $208.8 million.
Underwriting profit was nearly $23.6 million, down 31% year over year.
Combined ratio deteriorated 500 bps year over year to 90% in the second quarter.
Financial Update
Markel exited the second quarter with investments, cash and cash equivalents plus restricted cash and cash equivalents of $20.4 billion, down 0.8% from the level at year-end 2017.
Debt balance decreased 2.4% to $3 billion as of Jun 30, 2018 from $3.1 billion at 2017 end.
Book value per share slipped 1.8% from the tally at year-end 2017 to $682.76 as of Jun 30, 2018.
Net cash from operating activities for the first half was $307.5 million, up 29.2% year over year.
Zacks Rank
Markel carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performance of Other Insurers
Among other players from the insurance industry having already reported second-quarter earnings, the bottom line of The Progressive Corporation (PGR - Free Report) , MGIC Investment Corporation (MTG - Free Report) and RLI Corp. (RLI - Free Report) outpaced the respective Zacks Consensus Estimate.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>